Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by ""Natural IFN-producing cells"" (IPCs) as part of the host immune response and can also inhibit the development of tumors. IFN-beta binding by its receptor results in the activation of the tyrosine kinases Jak1 and Tyk2 and phosphorylation of members of the STAT family of transcription factors, leading to the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.
InvitrogenIFN beta Monoclonal Antibody (A1 (IFNb)), Functional Grade, eBioscience™ IFN beta Monoclonal Antibody (A1 (IFNb)), Functional Grade, eBioscience™
Cat # 16-9978-81
InvitrogenIFN beta Monoclonal Antibody (A1), FITC, eBioscience™ IFN beta Monoclonal Antibody (A1), FITC, eBioscience™
Cat # BMS1044FI
InvitrogenIFN beta Monoclonal Antibody (A1), Biotin, eBioscience™ IFN beta Monoclonal Antibody (A1), Biotin, eBioscience™
Cat # BMS1044BT
If an Invitrogen™ antibody doesn’t perform as described on our website or datasheet, we’ll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.